122 related articles for article (PubMed ID: 7509136)
1. Combination of immunosuppressive drugs for organ transplantation.
Ochiai T; Gunji Y; Nagata M; Isono K
Ann N Y Acad Sci; 1993 Nov; 696():270-80. PubMed ID: 7509136
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
Transplant Proc; 1995 Dec; 27(6):3314-5. PubMed ID: 8539967
[No Abstract] [Full Text] [Related]
3. Is there a rationale to combine cyclosporin and sirolimus?
Kahan BD
Nephrol Dial Transplant; 1996 Jan; 11(1):21-3. PubMed ID: 8649641
[No Abstract] [Full Text] [Related]
4. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive agents in kidney transplantation].
Nishi S
Nihon Jinzo Gakkai Shi; 2011; 53(1):1-5. PubMed ID: 21370569
[No Abstract] [Full Text] [Related]
6. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
7. [New developments in immunosuppressive therapy].
Hopt UT
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():620-3. PubMed ID: 11824327
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Jensen GS; Wiseman A; Trotter JF
Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
[No Abstract] [Full Text] [Related]
9. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Smith JM; Nemeth TL; McDonald RA
Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Chapman JR; Nankivell BJ
Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
[No Abstract] [Full Text] [Related]
11. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies.
Graham F; Racicot F; Jamali L; Cong VP; Raboisson MJ; Paradis J; Paradis L; Des Roches A
Ann Allergy Asthma Immunol; 2015 Aug; 115(2):155-7. PubMed ID: 26094803
[No Abstract] [Full Text] [Related]
12. Sirolimus-tacrolimus combination immunosuppression.
McAlister VC; Gao Z; Peltekian K; Domingues J; Mahalati K; MacDonald AS
Lancet; 2000 Jan; 355(9201):376-7. PubMed ID: 10665560
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
Wang M; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
[No Abstract] [Full Text] [Related]
14. Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.
Jacquet A; Francois H; Frangie C; Ahmad L; Charpentier B; Durrbach A
Transpl Immunol; 2008 Nov; 20(1-2):29-31. PubMed ID: 18817870
[TBL] [Abstract][Full Text] [Related]
15. [Immunosuppression with tacrolimus (FK 506) and cyclosporin A for preventing graft rejection after liver transplantation. Retrospective evaluation of medical costs based on the FG-O157 Study in 224 patients (Germany)].
Bachinger A; Kirchhoff D; Rychlik R
Chirurg; 1998 Sep; 69(9):957-62. PubMed ID: 9816454
[TBL] [Abstract][Full Text] [Related]
16. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
17. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study.
Ponticelli C; Salvadori M; Scolari MP; Citterio F; Rigotti P; Veneziano A; Bartezaghi M;
Transplantation; 2011 May; 91(10):e72-3. PubMed ID: 21540717
[No Abstract] [Full Text] [Related]
18. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus use in de "novo renal" transplantation.
Grinyo JM; Alonso A; Arias M; Campistol JM; González Molina M; González Posada JM; Morales JM; Oppenheimer F; Sánchez Fructuoso A; Sánchez-Plumed J; Ruiz JC
Nefrologia; 2006; 26 Suppl 2():33-51. PubMed ID: 17937633
[No Abstract] [Full Text] [Related]
20. [Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience].
Cardona M; Castel MÁ; Farrero M; Pérez-Villa F
Med Clin (Barc); 2013 Jul; 141(2):87-8. PubMed ID: 23384432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
